Jacqueline V Aredo

9PUBLICATIONS
140CO-AUTHORS
Molecular targetsPsychosocial aspects of childbirth and perinatal mental healthPredictive and prognostic markersCounselling, wellbeing and community servicesWomen's studies (incl. girls' studies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 22, 2026
Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancer.

|Jul 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.

Collin M Blakely, Anatoly Urisman, Matthew A Gubens

|May 24, 2024
Mindfulness in Facilitating Pelvic Floor Botulinum Toxin Injection in Women with Chronic Pelvic Pain.

Jacqueline V Aredo, Hannah K Tandon, Samin Panahi

|Apr 17, 2023
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.

Marcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti

|Mar 13, 2023
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations.

Michael J Grant, Jacqueline V Aredo, Jacqueline H Starrett

|Jun 01, 2022
Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study.

Jacqueline V Aredo, Eunji Choi, Victoria Y Ding

Pageof 2

Frequent Collaborators

4 joint publications

Heather A Wakelee

3 joint publications

Eunji Choi

3 joint publications

Loïc Le Marchand

2 joint publications

Sarah B Goldberg